J Nephropathol. 2012;1(3): 143-151. doi: 10.5812/nephropathol.8109
PMID: 24475405        PMCID: PMC3886156

Review Article

ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy


Cited by CrossRef: 17


1- Nasri H. Re Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism. 2013;39(4):375 [Crossref]
2- Davis T, Chubb S, Davis W. The relationship between estimated glomerular filtration rate trajectory and all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study. 2016;175(4):273 [Crossref]
3- Kallinikou D, Soldatou A, Tsentidis C, Louraki M, Kanaka‐Gantenbein C, Kanavakis E, Karavanaki K. Diabetic neuropathy in children and adolescents with type 1 diabetes mellitus: Diagnosis, pathogenesis, and associated genetic markers. Diabetes Metab Res Rev. 2019;:e3178 [Crossref]
4- Witzel I, Jelinek H, Khalaf K, Lee S, Khandoker A, Alsafar H. Identifying Common Genetic Risk Factors of Diabetic Neuropathies. Front Endocrinol. 2015;6 [Crossref]
5- Nasri H, Rafieian-Kopaei M. Garlic and Kidney Injury Protection. Shiraz E-Med J. 2013;14(4) [Crossref]
6- Baradaran A. Commentary on: effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial. DARU J Pharm Sci. 2013;21(1) [Crossref]
7- Mokretar K, Velinov H, Postadzhiyan A, Apostolova M. Association of Polymorphisms in Endothelial Nitric Oxide Synthesis and Renin–Angiotensin–Aldosterone System with Developing of Coronary Artery Disease in Bulgarian Patients. Genetic Testing and Molecular Biomarkers. 2016;20(2):67 [Crossref]
8- Nasri R. Renoprotective effects of metformin. DARU J Pharm Sci. 2013;21(1) [Crossref]
9- Aggarwal N, Kare P, Varshney P, Kalra O, Madhu S, Banerjee B, Yadav A, Raizada A, Tripathi A. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. WJD. 2017;8(3):112 [Crossref]
10- Saddick S. Angiotensin converting enzyme gene polymorphism studies: A case-control study. Saudi Journal of Biological Sciences. 2015;22(3):327 [Crossref]
11- Ai J, Liu Y, Zeng X, Lei Q, Zou L, Pei B. Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism and Vesicoureteral Reflux in Children. Medicine. 2015;94(52):e2421 [Crossref]
12- Vikulova O, Zheleznyakova A, Lebedeva N, Nikitin A, Nosikov V, Shestakova M. Genetic factors in the development of chronic kidney disease in patients with diabetes mellitus. Russ J Genet. 2017;53(4):420 [Crossref]
13- Savira M, Savira R, Syahputra M. Association of serum uric acid level and blood pressure in type 2 diabetes mellitus. IOP Conf Ser: Earth Environ Sci. 2018;125:012169 [Crossref]
14- Rafieian-Kopaei M, Nasri H. The Ameliorative Effect of Zingiber officinale in Diabetic Nephropathy. Iran Red Crescent Med J. 2014;16(5) [Crossref]
15- Викулова О, Железнякова А, Лебедева Н, Никитин А, Носиков В, Шестакова М. ГЕНЕТИЧЕСКИЕ ФАКТОРЫ В РАЗВИТИИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК ПРИ САХАРНОМ ДИАБЕТЕ, "Генетика". Генетика. 2017;(4):411 [Crossref]
16- Zou H, Wu G, Lv J, Xu G. Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor ( BDKRB2 ) polymorphism with diabetic nephropathy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017;1863(6):1264 [Crossref]